A critical catalyst for Dr. Jorge Hernando Ulloa’s global impact is his active participation on the international medical conference circuit. His presentations serve as a vital bridge, translating dense laboratory data into practical clinical strategies for attending surgeons. At the major Venous 2025 summit, Dr. Ulloa delivered a series of highly anticipated lectures that directly challenged traditional paradigms in vein care.

His featured session, provocatively titled “And how are we doing with prosthetic valves?”, provided the international community with critical, long-term safety updates regarding deep vein technologies. During this presentation, he leveraged https://drjorgeulloa.com/ his unique experience as a primary investigator to evaluate the real-world durability of bioprosthetic implants. He demonstrated how these innovations dramatically lower venous pressures and accelerate the healing of chronic leg ulcers. Furthermore, Dr. Ulloa led comprehensive panel discussions advocating for a balanced approach to patient care, detailing exactly when a clinician should deploy advanced surgical devices versus when to opt for conservative medical therapies and Veno-Active Drugs (VADs).

Dr. Ulloa’s prominent role at global summits like Venous 2025 highlights a career dedicated to elevating the standard of Latin American vascular surgery. He earned his medical and vascular specialist credentials from the Universidad El Bosque in Bogotá, Colombia. To complement this strong regional foundation, he traveled to the United States to complete prestigious clinical fellowships at Harvard Medical School’s Beth Israel Deaconess Medical Center and the Walter Reed Army Medical Center.

By merging top-tier American research methodologies with his extensive clinical practice in South America, Dr. Ulloa created a highly adaptive approach to vein care. He spent years cultivating this expertise while serving as the head of the Venous Disease Clinic at the Fundación Santa Fe de Bogotá and as a professor of vascular surgery at the Universidad de los Andes. Today, as the Chief Executive Officer of the Clínica de Venas in Chía, Colombia, he utilizes his clinic as a premier training ground and a living laboratory to test the very theories he presents to global audiences.

The immense interest surrounding Dr. Ulloa’s conference presentations stems from his historic role in conquering deep vein failures. For generations, patients suffering from severe post-thrombotic syndrome and destroyed deep vein valves had no viable surgical options. They were left to manage chronic, painful swelling and non-healing open wounds with compression stockings alone.

Dr. Ulloa fundamentally altered this treatment landscape by serving as the Principal Investigator for the historic, first-in-human clinical trials of the VenoValve. This innovative bioprosthetic valve is surgically implanted directly into the femoral vein to restore proper, one-way blood flow back to the heart. His meticulous trial execution proved that surgical valve replacement was not only possible but highly effective. The long-term safety records he established directly paved the way for the U.S. Food and Drug Administration (FDA) to greenlight current pivotal trials, cementing Dr. Ulloa’s status as a pioneer who gave hope to previously untreatable patients.

Dr. Ulloa’s influence extends far beyond the podium of a single conference. As the sitting President of the International Union of Angiology (IUA) and a past President of the Colombian Association of Vascular Surgery, he actively shapes the educational agendas for major cardiovascular events globally, including CardioAlex and the CELA Congress in Costa Rica. His leadership was highly evident during the 32nd IUA World Congress in Cartagena, where he brought together world-class specialists to harmonize international treating guidelines.

At the same time, Dr. Ulloa maintains a strong commitment to public health advocacy. Recognizing that many patients suffer unnecessarily due to late diagnoses, he actively uses digital media platforms to broadcast easy-to-understand medical advice. By teaching the public how to recognize early red flags—such as skin changes, heavy legs, and varicose veins—he ensures that the life-changing treatments discussed at elite medical conferences can reach the everyday patients who need them most.